Identifying Risk Factors for Secondary Malignancy in Breast Cancer Survivors

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

Lost in Space Game Night 42 min · 22 Sep 2026 · StarTalk with Neil deGrasse Tyson

AEE 2691: 3 Tips to Master Past Subjunctive Grammar 15 min · 22 Sep 2026 · All Ears English Podcast

Artificial Intimacy: Who We Become When We Talk to Machines (#320) 23 min · 22 Sep 2026 · 3 Takeaways™

RAW Reaction: 946 Kidnaps Solo Sikoa 25 min · 22 Sep 2026 · Busted Open

Auseinandernehmen erlaubt: Traumjob oder Wollmilchsau bei n8n? (279) 45 min · 22 Sep 2026 · PreSales Unleashed | Sales Engineering im B2B Software Vertrieb

Report any issue

Source

Recorded27 Apr 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648232

Show notes

The Cancer Advances podcast is joined by Abhay Singh, MD, MPH, a physician with the Department of Hematology and Medical Oncology at Cleveland Clinic to talk about his study, which aimed to identify risk factors for secondary malignancy in breast cancer survivors. This study was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Singh explains how he explored the different risk factors, such as G-CSF exposure, how the CHIP Clinic might be able to monitor patients, and the long-term goal to figure out which therapies patients should try to avoid.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in